| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |